This bio is strong despite a down open to the NASDAQ. Biomarker trial showed muted results but not bad enough to sell off the stock..so its most likely going higher. 1.272 is a reasonable target so looking for 13 dollars on the short end. Baseline of triangle should hold. play it safe , wait for break of upper trendline of triangle for a long position
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.